TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 60 | 54 | −6 |
| Shares | 5.67M | 5.84M | +170.3K (+3.0%) |
| Value | $54.5M | $45.1M | −$9.35M (−17.2%) |
New holders (10)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Corriente Advisors, LLC | 1,019,848 | $7.87M | 15.20% |
| Bridgeway Capital Management, LLC | 54,500 | $421.0K | 0.01% |
| MYDA Advisors LLC | 40,000 | $309.0K | 0.11% |
| Wolverine Trading, LLC | 33,889 | $258.0K | 0.01% |
| National Asset Management, Inc. | 26,800 | $207.0K | 0.01% |
| Charles Schwab Investment Management Inc | 11,966 | $93.0K | 0.00% |
| Marshall Wace, LLP | 11,951 | $92.0K | 0.00% |
| Caption Management, LLC | 2,238 | $17.0K | 0.00% |
| Brewin Dolphin Ltd | 725 | $5.60K | 0.00% |
| Royal Bank of Canada | 500 | $4.00K | 0.00% |
Sold out (16)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Granite Point Capital Management, L.P. | 210,000 | $2.02M |
| Iridian Asset Management LLC | 157,981 | $1.52M |
| Hudson Bay Capital Management LP | 100,000 | $961.0K |
| P.A.W. Capital Corp | 75,000 | $721.0K |
| First Trust Advisors LP | 37,350 | $359.0K |
| Ergoteles LLC | 26,717 | $257.0K |
| Cubist Systematic Strategies, LLC | 25,300 | $243.0K |
| Precept Management LLC | 15,000 | $144.0K |
| Belvedere Trading LLC | 14,850 | $137.0K |
| D. E. Shaw & Co., Inc. | 14,105 | $136.0K |
| Trexquant Investment LP | 12,226 | $117.0K |
| Occudo Quantitative Strategies LP | 11,901 | $114.0K |
| Venturi Wealth Management, LLC | 8,273 | $80.0K |
| Tower Research Capital LLC (TRC) | 5,276 | $50.0K |
| FMR LLC | 1 | $0 |
| O'Shaughnessy Asset Management, LLC | 28 | $0 |